All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 139.36 Million TWD | -62.15% |
| 2022 | 368.2 Million TWD | 85.84% |
| 2021 | 198.12 Million TWD | 141.02% |
| 2020 | 82.2 Million TWD | 130.3% |
| 2019 | 35.69 Million TWD | -88.3% |
| 2018 | 305.05 Million TWD | -5.52% |
| 2017 | 322.87 Million TWD | 32.75% |
| 2016 | 243.21 Million TWD | 23.42% |
| 2015 | 197.06 Million TWD | 0.73% |
| 2014 | 195.63 Million TWD | 23.45% |
| 2013 | 158.47 Million TWD | -24.66% |
| 2012 | 210.36 Million TWD | 29.6% |
| 2011 | 162.32 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 16.85 Million TWD | -72.05% |
| 2024 Q1 | 28.48 Million TWD | 433.55% |
| 2023 Q3 | 68.7 Million TWD | 76.76% |
| 2023 Q2 | 38.86 Million TWD | -36.11% |
| 2023 Q1 | 60.83 Million TWD | 30.37% |
| 2023 FY | 139.36 Million TWD | -62.15% |
| 2023 Q4 | -8.54 Million TWD | -112.43% |
| 2022 Q1 | 68.5 Million TWD | -14.33% |
| 2022 FY | 368.2 Million TWD | 85.84% |
| 2022 Q4 | 46.66 Million TWD | -70.6% |
| 2022 Q2 | 94.33 Million TWD | 37.7% |
| 2022 Q3 | 158.69 Million TWD | 68.23% |
| 2021 Q3 | 48.88 Million TWD | 15.94% |
| 2021 Q4 | 79.96 Million TWD | 63.58% |
| 2021 FY | 198.12 Million TWD | 141.02% |
| 2021 Q2 | 42.16 Million TWD | 55.47% |
| 2021 Q1 | 27.12 Million TWD | -23.11% |
| 2020 Q3 | 34.53 Million TWD | -10.56% |
| 2020 Q4 | 35.27 Million TWD | 2.14% |
| 2020 Q1 | -26.2 Million TWD | -2771.56% |
| 2020 FY | 82.2 Million TWD | 130.3% |
| 2020 Q2 | 38.61 Million TWD | 247.32% |
| 2019 Q3 | 6.44 Million TWD | -76.75% |
| 2019 Q4 | 981 Thousand TWD | -84.79% |
| 2019 FY | 35.69 Million TWD | -88.3% |
| 2019 Q1 | 526 Thousand TWD | -98.13% |
| 2019 Q2 | 27.73 Million TWD | 5173.57% |
| 2018 Q2 | 115.93 Million TWD | 66.25% |
| 2018 FY | 305.05 Million TWD | -5.52% |
| 2018 Q4 | 28.05 Million TWD | -69.28% |
| 2018 Q3 | 91.32 Million TWD | -21.23% |
| 2018 Q1 | 69.73 Million TWD | 6.15% |
| 2017 Q3 | 90.37 Million TWD | -7.27% |
| 2017 Q2 | 97.46 Million TWD | 40.58% |
| 2017 Q1 | 69.33 Million TWD | 33.15% |
| 2017 FY | 322.87 Million TWD | 32.75% |
| 2017 Q4 | 65.69 Million TWD | -27.31% |
| 2016 Q2 | 67.71 Million TWD | 35.95% |
| 2016 Q3 | 73.62 Million TWD | 8.74% |
| 2016 Q4 | 52.06 Million TWD | -29.28% |
| 2016 Q1 | 49.8 Million TWD | -18.91% |
| 2016 FY | 243.21 Million TWD | 23.42% |
| 2015 FY | 197.06 Million TWD | 0.73% |
| 2015 Q2 | 90.07 Million TWD | 2203.04% |
| 2015 Q4 | 61.42 Million TWD | 23.21% |
| 2015 Q3 | 49.85 Million TWD | -44.65% |
| 2015 Q1 | -4.28 Million TWD | 0.0% |
| 2014 FY | 195.63 Million TWD | 23.45% |
| 2013 FY | 158.47 Million TWD | -24.66% |
| 2013 Q1 | 42.19 Million TWD | -53.02% |
| 2012 FY | 210.36 Million TWD | 29.6% |
| 2012 Q4 | 89.79 Million TWD | 0.0% |
| 2011 FY | 162.32 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Sinon Corporation | 1.05 Billion TWD | 86.763% |
| Taiwan Fertilizer Co., Ltd. | 3.91 Billion TWD | 96.444% |
| CH Biotech R&D Co., Ltd. | 463.29 Million TWD | 69.919% |